Features

Center will study rare genetic diseases

Center will study rare genetic diseases

$11 million grant makes Yale home to one of three national centers tasked with unraveling the genetic causes of rare inherited diseases

For complex diseases like cancer and diabetes, there’s no crystal ball that can tell you for sure whether you’ll develop the illness during your lifetime. A tangled interplay between your environment, your behaviors, and the genes you inherited from your parents determines your risk of such diseases. But for some disorders—dubbed Mendelian—a mutation in a single gene is the direct and clear-cut cause of disease. And the inheritance patterns of Mendelian disorders are also straightforward, but...

Read more...

Center will study rare genetic diseases

Gift brings personalized cancer therapy a step closer to reality

When Roy S. Herbst, M.D., Ph.D., joined Yale as professor of medicine, associate director for translational research, and chief of medical oncology at Smilow Cancer Hospital at Yale-New Haven last March, his arrival was seen as an important step toward the vision Yale Cancer Center (YCC) Director Thomas J. Lynch, M.D., had begun articulating in 2009.

That vision centers on “personalized” cancer treatment—therapy...

Read more...

Now a department, urology recruits its inaugural leader

Now a department, urology recruits its inaugural leader

In January, Dean Robert J. Alpern, M.D., and Marna P. Borgstrom, M.P.H., president and CEO of the Yale-New Haven Health System, announced the appointment of Peter G. Schulam, M.D., Ph.D., as chair of the Department of Urology at the School of Medicine and chief of the urology...

Read more...